The International Association for Quality Assurance in Pre-Tertiary and Higher Education (QAHE) is pleased to announce that Dr Francis O. Akenami has been awarded the Honorary Professor of Practice in Regulatory Writing and Scientific Publishing.
The title recognises professional practice in the preparation of regulatory and scientific documents. Dr Akenami holds a PhD in Neuropathology and Clinical Chemistry from the University of Helsinki, an MSc in Chemical Pathology from University College Hospital, Ibadan, and a BMLS from the University of Science and Technology, Port Harcourt.
He has worked as a scientific and regulatory writer at Bayer HealthCare Pharmaceuticals (2013–2017) and as Senior Medical Writer and Senior Clinical Scientist at Merck Pharmaceuticals (2017–2019). Since 2019 he has founded and directed THINKCZAR LLC, preparing clinical overviews, ICH Module 2.7 and Module 4 documents, protocols, clinical study reports, investigator brochures, and responses to health-authority questions. Since January 2023 he has served as Managing Editor of the Spartan Medical Research Journal, overseeing peer-review operations and publication standards.
Earlier posts include research and teaching roles at the University of Helsinki, The Rockefeller University, and the Hospital for Special Surgery / Weill Medical College of Cornell University. He is a Fellow of the Institute of Medical Laboratory Sciences, Nigeria, and a member of the American Medical Writers Association.
The Honorary Professor of Practice is an honorific title of QAHE. It is not a salaried chair, not a licence to practise as a professor, and not an academic degree. It records recognition of documented professional practice in regulatory writing and scientific publishing.
QAHE congratulates Dr Francis O. Akenami on the award.
For further information, visit www.qahe.org.
